-
What's new
- All What's new
-
European
- What's new - All
- <hr>
- What's new - last 24 hrs
- What's new - last 7 days
- What's new - last 30 days
- <hr>
- New EU Legislation
- European Commission
- European Banking Authority
- European Securities and Markets Authority
- European Insurance and Occupational Pensions Authority
- <hr>
- Consultations and similar
- Commentaries
- <hr>
- Downloads and Exports
- Latest news by Topics
-
International
- What's new - All
- <hr>
- What's new - last 24 hrs
- What's new - last 7 days
- What's new - last 30 days
- <hr>
- Bank for International Settlements
- Basel Committee on Banking Supervision
- Egmont Group
- International Association of Insurance Supervisors
- International Monetary Fund
- <hr>
- Consultations and similar
- Commentaries
- <hr>
- Downloads and Exports
- Latest news by Topics
- Downloads and Exports
- Legislation
- Organisations
-
Commentaries
- Consultations
- Sanctioned regimes
- IFRSs
- Regulatory calendar
- Quicklinks
-
More
Table of Contents
Related
Document Overview
AI Summary of Article 2a Equivalence decisions for the purposes of the definition of OTC derivatives
According to Article 2(7) of the Regulation, a third-country market is deemed equivalent to a regulated market as defined in Article 4(1)(14) of Directive 2004/39/EC if it adheres to legally binding requirements comparable to those outlined in Title III of that Directive, and is subjected to effective ongoing supervision and enforcement by the relevant authority in the third country. This assessment is carried out by the Commission in accordance with the specified procedural guidelines.
The Commission has the authority to adopt implementing acts to formally recognise a third-country market's compliance with these equivalency requirements. These acts will follow the examination procedure described in Article 86(2) of the Regulation. Furthermore, the Commission and ESMA are tasked with publishing and maintaining an updated list of markets considered equivalent under the implementing acts.
AI Disclaimer
Please note that AI-generated content should not be considered legal advice. Users are encouraged to consult with qualified professionals or legal advisors where specific legal guidance is required.
We are committed to transparency and responsible use of AI in a way that supports, but never replaces, human expertise.
If you have any questions or concerns about the use of AI on our platform, please feel free to contact us.
Article 2a Equivalence decisions for the purposes of the definition of OTC derivatives
1. For the purposes of Article 2(7) of this Regulation, a third-country market shall be considered to be equivalent to a regulated market within the meaning of Article 4(1)(14) of Directive 2004/39/EC where it complies with legally binding requirements which are equivalent to the requirements laid down in Title III of that Directive and it is subject to effective supervision and enforcement in that third country on an ongoing basis, as determined by the Commission in accordance with the procedure referred to in paragraph 2 of this Article.
2. The Commission may adopt implementing acts determining that a third-country market complies with legally binding requirements which are equivalent to the requirements laid down in Title III of Directive 2004/39/EC and it is subject to effective supervision and enforcement in that third country on an ongoing basis for the purposes of paragraph 1.
Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 86(2) of this Regulation.
3. The Commission and ESMA shall publish on their websites a list of those markets that are to be considered to be equivalent in accordance with the implementing act referred to in paragraph 2. That list shall be updated periodically.